腕管综合征患者发生化脓性汗腺炎的风险:一项基于人群的队列研究

IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
In vivo Pub Date : 2025-09-01 DOI:10.21873/invivo.14093
Chih-Lung Wu, Yu-Jung Su, Hui-Chin Chang, Ya-Hsuan Wu, Yi-Sheng Jhang, Meng-Che Wu, Shiu-Jau Chen, Shuo-Yan Gau
{"title":"腕管综合征患者发生化脓性汗腺炎的风险:一项基于人群的队列研究","authors":"Chih-Lung Wu, Yu-Jung Su, Hui-Chin Chang, Ya-Hsuan Wu, Yi-Sheng Jhang, Meng-Che Wu, Shiu-Jau Chen, Shuo-Yan Gau","doi":"10.21873/invivo.14093","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Carpal tunnel syndrome (CTS) and hidradenitis suppurativa (HS) are chronic inflammatory conditions that significantly affect quality of life. While both disorders have distinct manifestations, they share common risk factors such as obesity and systemic inflammation. This study aimed to evaluate whether CTS is associated with an increased risk of HS.</p><p><strong>Patients and methods: </strong>We conducted a retrospective cohort study using data from the TriNetX Global Health Research Network. Adults diagnosed with CTS were matched 1:1 with controls without CTS, based on age, sex, race, body mass index (BMI), comorbidities, socioeconomic status, and healthcare utilization. Individuals with prior HS or cancer were excluded. The primary outcome was new-onset HS, identified by ICD-10 codes. Hazard ratios (HRs) with 95% confidence intervals (CIs). Sensitivity analyses incorporated varied wash-out periods, alternative CTS definitions, and different follow-up durations.</p><p><strong>Results: </strong>After matching, 493,181 patients were included in each group. Over a 15-year follow-up period, patients with CTS showed a significantly higher risk of HS (HR=1.739; 95%CI=1.617-1.871). Sensitivity analyses validated the robustness of the results, with HRs ranging from 1.647 (95%CI=1.572-1.726) to 2.142 (95%CI=1.979-2.318) across different models. In stratified analyses, the association remained significant across all subgroups. Among males, the HR was 1.249 (95%CI=1.042-1.498), whereas among females, it was 1.739 (95%CI=1.606-1.884). Patients aged 18-64 years had an HR of 1.772 (95%CI=1.642-1.913), while those aged ≥65 years had an HR of 1.479 (95%CI=1.146-1.907).</p><p><strong>Conclusion: </strong>CTS is significantly associated with an increased risk of HS. These findings suggest a possible shared inflammatory pathway, and dermatologic comorbidities in CTS patients should be carefully considered.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 5","pages":"2931-2939"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396054/pdf/","citationCount":"0","resultStr":"{\"title\":\"Risk of Hidradenitis Suppurativa in Patients With Carpal Tunnel Syndrome: A Population-based Cohort Study.\",\"authors\":\"Chih-Lung Wu, Yu-Jung Su, Hui-Chin Chang, Ya-Hsuan Wu, Yi-Sheng Jhang, Meng-Che Wu, Shiu-Jau Chen, Shuo-Yan Gau\",\"doi\":\"10.21873/invivo.14093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>Carpal tunnel syndrome (CTS) and hidradenitis suppurativa (HS) are chronic inflammatory conditions that significantly affect quality of life. While both disorders have distinct manifestations, they share common risk factors such as obesity and systemic inflammation. This study aimed to evaluate whether CTS is associated with an increased risk of HS.</p><p><strong>Patients and methods: </strong>We conducted a retrospective cohort study using data from the TriNetX Global Health Research Network. Adults diagnosed with CTS were matched 1:1 with controls without CTS, based on age, sex, race, body mass index (BMI), comorbidities, socioeconomic status, and healthcare utilization. Individuals with prior HS or cancer were excluded. The primary outcome was new-onset HS, identified by ICD-10 codes. Hazard ratios (HRs) with 95% confidence intervals (CIs). Sensitivity analyses incorporated varied wash-out periods, alternative CTS definitions, and different follow-up durations.</p><p><strong>Results: </strong>After matching, 493,181 patients were included in each group. Over a 15-year follow-up period, patients with CTS showed a significantly higher risk of HS (HR=1.739; 95%CI=1.617-1.871). Sensitivity analyses validated the robustness of the results, with HRs ranging from 1.647 (95%CI=1.572-1.726) to 2.142 (95%CI=1.979-2.318) across different models. In stratified analyses, the association remained significant across all subgroups. Among males, the HR was 1.249 (95%CI=1.042-1.498), whereas among females, it was 1.739 (95%CI=1.606-1.884). Patients aged 18-64 years had an HR of 1.772 (95%CI=1.642-1.913), while those aged ≥65 years had an HR of 1.479 (95%CI=1.146-1.907).</p><p><strong>Conclusion: </strong>CTS is significantly associated with an increased risk of HS. These findings suggest a possible shared inflammatory pathway, and dermatologic comorbidities in CTS patients should be carefully considered.</p>\",\"PeriodicalId\":13364,\"journal\":{\"name\":\"In vivo\",\"volume\":\"39 5\",\"pages\":\"2931-2939\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396054/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In vivo\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/invivo.14093\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.14093","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:腕管综合征(Carpal tunnel syndrome, CTS)和化脓性汗腺炎(hidradenitis化脓性汗腺炎)是严重影响生活质量的慢性炎症。虽然这两种疾病有不同的表现,但它们有共同的危险因素,如肥胖和全身性炎症。本研究旨在评估CTS是否与HS风险增加相关。患者和方法:我们使用TriNetX全球健康研究网络的数据进行了一项回顾性队列研究。根据年龄、性别、种族、体重指数(BMI)、合并症、社会经济地位和医疗保健利用情况,将诊断为CTS的成年人与未诊断为CTS的对照组进行1:1匹配。既往患有HS或癌症的个体被排除在外。主要结局为新发HS,由ICD-10编码确定。风险比(hr)和95%置信区间(ci)。敏感性分析包括不同的洗脱期、不同的CTS定义和不同的随访时间。结果:配对后,两组共纳入患者493181例。在15年的随访期间,CTS患者发生HS的风险显著增高(HR=1.739; 95%CI=1.617-1.871)。敏感性分析验证了结果的稳健性,不同模型的hr范围为1.647 (95%CI=1.572-1.726)至2.142 (95%CI=1.979-2.318)。在分层分析中,该关联在所有亚组中仍然显著。男性的HR为1.249 (95%CI=1.042 ~ 1.498),女性的HR为1.739 (95%CI=1.606 ~ 1.884)。18-64岁患者的HR为1.772 (95%CI=1.642-1.913),≥65岁患者的HR为1.479 (95%CI=1.146-1.907)。结论:CTS与HS发病风险增高有显著相关性。这些发现提示可能存在共同的炎症途径,CTS患者的皮肤合并症应仔细考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Risk of Hidradenitis Suppurativa in Patients With Carpal Tunnel Syndrome: A Population-based Cohort Study.

Risk of Hidradenitis Suppurativa in Patients With Carpal Tunnel Syndrome: A Population-based Cohort Study.

Risk of Hidradenitis Suppurativa in Patients With Carpal Tunnel Syndrome: A Population-based Cohort Study.

Risk of Hidradenitis Suppurativa in Patients With Carpal Tunnel Syndrome: A Population-based Cohort Study.

Background/aim: Carpal tunnel syndrome (CTS) and hidradenitis suppurativa (HS) are chronic inflammatory conditions that significantly affect quality of life. While both disorders have distinct manifestations, they share common risk factors such as obesity and systemic inflammation. This study aimed to evaluate whether CTS is associated with an increased risk of HS.

Patients and methods: We conducted a retrospective cohort study using data from the TriNetX Global Health Research Network. Adults diagnosed with CTS were matched 1:1 with controls without CTS, based on age, sex, race, body mass index (BMI), comorbidities, socioeconomic status, and healthcare utilization. Individuals with prior HS or cancer were excluded. The primary outcome was new-onset HS, identified by ICD-10 codes. Hazard ratios (HRs) with 95% confidence intervals (CIs). Sensitivity analyses incorporated varied wash-out periods, alternative CTS definitions, and different follow-up durations.

Results: After matching, 493,181 patients were included in each group. Over a 15-year follow-up period, patients with CTS showed a significantly higher risk of HS (HR=1.739; 95%CI=1.617-1.871). Sensitivity analyses validated the robustness of the results, with HRs ranging from 1.647 (95%CI=1.572-1.726) to 2.142 (95%CI=1.979-2.318) across different models. In stratified analyses, the association remained significant across all subgroups. Among males, the HR was 1.249 (95%CI=1.042-1.498), whereas among females, it was 1.739 (95%CI=1.606-1.884). Patients aged 18-64 years had an HR of 1.772 (95%CI=1.642-1.913), while those aged ≥65 years had an HR of 1.479 (95%CI=1.146-1.907).

Conclusion: CTS is significantly associated with an increased risk of HS. These findings suggest a possible shared inflammatory pathway, and dermatologic comorbidities in CTS patients should be carefully considered.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
In vivo
In vivo 医学-医学:研究与实验
CiteScore
4.20
自引率
4.30%
发文量
330
审稿时长
3-8 weeks
期刊介绍: IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信